These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 20663455)
1. Patient perceptions of different lancing sites for self-monitoring of blood glucose: a comparison of fingertip site with palm site using the OneTouch Ultra Blood Glucose Monitoring System. Ito T; Kamoi K; Minagawa S; Kimura K; Kobayashi A J Diabetes Sci Technol; 2010 Jul; 4(4):906-10. PubMed ID: 20663455 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the OneTouch® Delica™: a low-pain lancing system for self-monitoring of blood glucose. Ginsberg BH; Shemain A; Pines MK; Wallace DA; Pineau M Postgrad Med; 2011 Jul; 123(4):92-8. PubMed ID: 21680993 [TBL] [Abstract][Full Text] [Related]
3. Palm glucose readings compared with fingertip readings under steady and dynamic glycemic conditions, using the OneTouch Ultra Blood Glucose Monitoring System. Kempe KC; Budd D; Stern M; Ellison JM; Saari LA; Adiletto CA; Olin B; Price DA; Horwitz DL Diabetes Technol Ther; 2005 Dec; 7(6):916-26. PubMed ID: 16386098 [TBL] [Abstract][Full Text] [Related]
4. Effect of an experiential exercise in diabetes management on pharmacy students' fear and perceived pain of injection and fingertip lancing. Sahnan A; Simpson SH Am J Pharm Educ; 2015 Feb; 79(1):05. PubMed ID: 25741021 [TBL] [Abstract][Full Text] [Related]
5. Alternate site testing for hemoglobin A1C in children with diabetes. Flores SL Diabetes Educ; 2010; 36(4):623-8. PubMed ID: 20693439 [TBL] [Abstract][Full Text] [Related]
6. Comparison of lancing devices for self-monitoring of blood glucose regarding lancing pain. Kocher S; Tshiananga JK; Koubek R J Diabetes Sci Technol; 2009 Sep; 3(5):1136-43. PubMed ID: 20144427 [TBL] [Abstract][Full Text] [Related]
7. Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study). Harashima S; Fukushima T; Sasaki M; Nishi Y; Fujimoto S; Ogura M; Yamane S; Tanaka D; Harada N; Hamasaki A; Nagashima K; Nakahigashi Y; Seino Y; Inagaki N Diabetes Metab Res Rev; 2013 Jan; 29(1):77-84. PubMed ID: 23008090 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Bina DM; Anderson RL; Johnson ML; Bergenstal RM; Kendall DM Diabetes Care; 2003 Apr; 26(4):981-5. PubMed ID: 12663560 [TBL] [Abstract][Full Text] [Related]
10. Does Site Matter? Comparing Accuracy and Patient Comfort of Blood Glucose Samples Taken From the Finger and Palm of the Perioperative Patient. Farmer L; Winfield C; Quatrara B; Letzkus L; Schenck P; Finneran P; Pollak D; McCaskill C; Nealy R; Conaway M J Perianesth Nurs; 2017 Dec; 32(6):573-577. PubMed ID: 29157763 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of OneTouch Verio(®), a new blood glucose self-monitoring system for patients with diabetes. Littmann K; Petersen ER; Pussinen C; Danielson K; Djurisic S; Eilertsen H; Garabet L; Greibe E; Lauritzen T; Olsen DA; Othman S; Palimaru I; Westerlund J Scand J Clin Lab Invest; 2013; 73(4):286-92. PubMed ID: 23473019 [TBL] [Abstract][Full Text] [Related]
12. Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes. Kesavadev J; Chandran GB; Basanth A; Krishnan G; Shankar A; Jothydev S Diabetes Metab Syndr; 2023 Mar; 17(3):102731. PubMed ID: 36893684 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the comparison of lancing devices for self-monitoring of blood glucose regarding lancing pain. Lekarcyk J; Ghiloni S J Diabetes Sci Technol; 2009 Sep; 3(5):1144-5. PubMed ID: 20144428 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Fingertip vs Palm Site Sampling on Pain Perception, and Variation in Capillary Blood Glucose Level among Patients with Diabetes Mellitus. Anitha Pavithran A; Ramamoorthy L; Bs S; Murugesan R; Mj K J Caring Sci; 2020 Dec; 9(4):182-187. PubMed ID: 33409161 [No Abstract] [Full Text] [Related]
15. Accuracy and user performance evaluation of a blood glucose monitoring system. Caswell M; Frank J; Viggiani MT; Pardo S; Dunne N; Warchal-Windham ME; Morin R Diabetes Technol Ther; 2015 Mar; 17(3):152-8. PubMed ID: 25494048 [TBL] [Abstract][Full Text] [Related]
16. Alternative site blood glucose testing: a multicenter study. Fedele D; Corsi A; Noacco C; Prisco F; Squatrito S; Torre E; Iafusco D; Errico MK; Toniato R; Nicolucci A; Franciosi M; De Berardis G; Neri L Diabetes Technol Ther; 2003; 5(6):983-9. PubMed ID: 14709201 [TBL] [Abstract][Full Text] [Related]
17. An analysis of alternate site tests to improve patient compliance with self-monitoring of blood glucose. Jacoby JM J Diabetes Sci Technol; 2010 Jul; 4(4):911-2. PubMed ID: 20663456 [TBL] [Abstract][Full Text] [Related]
18. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles. Iwanaga M; Kamoi K Diabetes Technol Ther; 2009 Feb; 11(2):81-6. PubMed ID: 19848573 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetes. Wilhelm B; Forst S; Weber MM; Larbig M; Pfützner A; Forst T Diabetes Technol Ther; 2006 Apr; 8(2):146-55. PubMed ID: 16734545 [TBL] [Abstract][Full Text] [Related]
20. Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Koschinsky T; Jungheim K; Heinemann L Diabetes Technol Ther; 2003; 5(5):829-42. PubMed ID: 14633348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]